Inflammatory bowel diseases (IBD) such as Crohn's disease (CD) and ulcerative colitis (UC) constitute a major health problem in developed countries. Moreover, IBD predisposes to the development of colorectal cancer. Although the precise etiology of CD and UC remains unclear, aberrant immune responses against commensal microflora are widely thought to underlie IBD. Multiple receptors of the extracellular interleukin (IL) receptor and Toll-like receptor (TLR) families are expressed on epithelial and immune cells in the gastro-intestinal tract and have been implicated in IBD. More recently, single nucleotide polymorphisms (SNPs) in the genes encoding the NOD-like receptor (NLR) family members Nod2 and Nlrp3 were linked to CD susceptibility. Peptidoglycan fragments from bacteria activate Nod2, which triggers recruitment of the adaptor protein Rip2 resulting in K63- linked ubiquitylation and activation of NF-?B and MAP kinase signaling cascades. Our studies show that both Nod2 and Rip2 are critical regulators preventing destructive inflammatory immune responses in the intestinal inflammation and colorectal tumorigenesis. However, although Rip2 is downstream of Nod2 in activating NF-kB pathway, surprisingly, our findings indicate previously undefined and divergent roles for Nod2 and Rip2. Altogether, the major goals of this proposal are to mechanistically define the molecular basis underlying regulation of intestinal immune response to colitis-associated colorectal tumorigenesis by Nod2 and Rip2 signaling. The proposed studies give insight into the key overlapping and non-overlapping molecular mechanisms by which NLR/Nod2/Rip2 participate in IBD and colorectal tumorigenesis and create new therapeutic options for devastating inflammatory diseases.

Public Health Relevance

Innate immune system has been suggested to mediate the development of intestinal inflammation and carcinogenesis. Nonetheless, the role of distinct innate immune signaling pathways in the development of inflammation and colorectal tumorigenesis is yet to be unraveled. The proposed studies will contribute to our insight into the key molecular mechanisms by which Nod2 and Rip2 participate in IBD and colorectal tumorigenesis and create new therapeutic options for devastating inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA163507-01A1
Application #
8373063
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Daschner, Phillip J
Project Start
2012-07-09
Project End
2017-04-30
Budget Start
2012-07-09
Budget End
2013-04-30
Support Year
1
Fiscal Year
2012
Total Cost
$363,125
Indirect Cost
$155,625
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Tartey, Sarang; Gurung, Prajwal; Dasari, Tejasvi Krishna et al. (2018) ASK1/2 signaling promotes inflammation in a mouse model of neutrophilic dermatosis. J Clin Invest 128:2042-2047
Karki, Rajendra; Lee, Ein; Place, David et al. (2018) IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. Cell 173:920-933.e13
Malireddi, R K Subbarao; Gurung, Prajwal; Mavuluri, Jayadev et al. (2018) TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. J Exp Med 215:1023-1034
Sharma, Deepika; Malik, Ankit; Guy, Clifford S et al. (2018) Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis. Gastroenterology 154:948-964.e8
Malik, Ankit; Kanneganti, Thirumala-Devi (2018) Function and regulation of IL-1? in inflammatory diseases and cancer. Immunol Rev 281:124-137
Place, David E; Kanneganti, Thirumala-Devi (2018) Recent advances in inflammasome biology. Curr Opin Immunol 50:32-38
Zhu, Qifan; Zheng, Min; Balakrishnan, Arjun et al. (2018) Gasdermin D Promotes AIM2 Inflammasome Activation and Is Required for Host Protection against Francisella novicida. J Immunol 201:3662-3668
Kuriakose, Teneema; Kanneganti, Thirumala-Devi (2018) ZBP1: Innate Sensor Regulating Cell Death and Inflammation. Trends Immunol 39:123-134
Kuriakose, Teneema; Kanneganti, Thirumala-Devi (2018) Is Inflammasome a Potential Target of Prophylaxis in Rheumatic Heart Disease? Circulation 138:2662-2665
Zhu, Qifan; Man, Si Ming; Karki, Rajendra et al. (2018) Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome Responses during Francisella novicida Infection. Cell Rep 22:3168-3174

Showing the most recent 10 out of 75 publications